oseltamivir has been researched along with Infant, Premature, Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Blyth, CC; Cheng, AC; Macartney, KK; McRae, JE; Quinn, HE; Wood, NJ | 1 |
| Basson, E; Boibieux, A; Haÿs, S; Leick-Courtois, C; Mory-Thomas, N; Picaud, JC | 1 |
| Barak, S; Chulski, E; Kushnir, A; Miron, D | 1 |
| Jankovic, B; Martic, J; Minic, P; Nedeljkovic, J; Pasic, S; Savic, N | 1 |
| Bekker, A; Cotton, MF; Holgate, SL; Rabie, H | 1 |
| Felderhoff-Müser, U; Göpel, W; Härtel, C; Heitmann, F; Hoehn, T; Keller, M; Roggendorf, M; Ross, S; Stein, A | 1 |
6 other study(ies) available for oseltamivir and Infant, Premature, Diseases
| Article | Year |
|---|---|
Risk factors and disease severity in Australian infants aged under 6 months hospitalised with influenza 2011-2019.
Topics: Australia; Cross Infection; Female; Hospitalization; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Influenza Vaccines; Influenza, Human; Male; Oseltamivir; Prospective Studies; Risk Factors; Severity of Illness Index | 2022 |
Oseltamivir treatment for influenza does not increase digestive intolerance in preterm infants.
Topics: Antiviral Agents; Digestion; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Retrospective Studies | 2014 |
Influenza A/H1N1 virus in very low-birth-weight premature infant: case report.
Topics: Antiviral Agents; Apnea; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intermittent Positive-Pressure Ventilation; Male; Oseltamivir | 2010 |
Novel H1N1 influenza in neonates: from mild to fatal disease.
Topics: Antiviral Agents; Diagnosis, Differential; Fatal Outcome; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pandemics; Prognosis; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors | 2011 |
Oseltamivir use in low-birth weight infants during the 2009 nH1N1 influenza a outbreak in the Western Cape, South Africa.
Topics: Antiviral Agents; Disease Outbreaks; Enterocolitis, Necrotizing; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; South Africa; Treatment Outcome | 2012 |
Pandemic A/H1N1(2009) influenza infections in very-low-birth-weight infants--a case series from the German Neonatal Network.
Topics: Antiviral Agents; Cause of Death; Cross Infection; Diagnosis, Differential; Female; Germany; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral; Respiratory Distress Syndrome, Newborn; Risk Factors; Sepsis; Survival Rate | 2011 |